Bioengineering

A two-day event at the Stanford School of Medicine brought together investors, regulators, company executives and scientists to discuss the most productive ways for them to work together.

In a study led by Stanford Medicine, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats aggressive tumors in mice.

Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

In the five decades since the emergence of recombinant DNA technology, researchers at Stanford Medicine have benefited from the close involvement of bioethics experts.

Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.

The Stanford psychiatrist, neuroscientist and engineer is honored for developing a technology that lets researchers pinpoint the functions — and malfunctions — of specific brain circuits.

A computer simulation that relates muscle activation patterns to harmful pressure on the knee helps participants adopt knee-protective strategies as they walk.

A Stanford scientist and his colleagues show that patients fitted with a chip in their eye are able to integrate what the chip “sees” with objects their natural peripheral vision detects.

A training program for health technology innovators, the center has generated medical technologies that have helped millions of patients and inspired similar training programs worldwide.

Discoveries by Deisseroth and his two co-recipients regarding microbial light-activated molecules led to his development of a way to manipulate selected neurons in living animals to observe changes in their behavior.

CAR-T cell therapy works for many types of blood cancers, but more than half of patients relapse. A Stanford study provides a clue as to why.